ASHLEY CUTINI: Open Payments
NPI 1366952475 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 31 payments from 9 companies in 2025. Trend: 2023 $207 · 2024 $393 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $351 |
| Madrigal Pharmaceuticals | 6 | $134 |
| Ipsen Biopharmaceuticals, Inc | 6 | $122 |
| ANI Pharmaceuticals, Inc. | 3 | $78 |
| Novo Nordisk Inc | 2 | $42 |
| Mirum Pharmaceuticals, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| ORPHALAN INC | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
Products named: TERLIVAZ, REZDIFFRA, IQIRVO, PURIFIED CORTROPHIN GEL, Wegovy, Livmarli, PREVYMIS, CUVRIOR.
Industry payments across GA — which companies pay providers there.
